Literature DB >> 35612780

BAG2 prevents Tau hyperphosphorylation and increases p62/SQSTM1 in cell models of neurodegeneration.

Raquel S Lima1, Daniel C Carrettiero2, Merari F R Ferrari3.   

Abstract

BACKGROUND: Protein aggregates are pathological hallmarks of many neurodegenerative diseases, however the physiopathological role of these aggregates is not fully understood. Protein quality control has a pivotal role for protein homeostasis and depends on specific chaperones. The co-chaperone BAG2 can target phosphorylated Tau for degradation by an ubiquitin-independent pathway, although its possible role in autophagy was not yet elucidated. In view of this, the aim of the present study was to investigate the association among protein aggregation, autophagy and BAG2 levels in cultured cells from hippocampus and locus coeruleus as well as in SH-SY5Y cell line upon different protein aggregation scenarios induced by rotenone, which is a flavonoid used as pesticide and triggers neurodegeneration. METHODS AND
RESULTS: The present study showed that rotenone exposure at 0.3 nM for 48 h impaired autophagy prior to Tau phosphorylation at Ser199/202 in hippocampus but not in locus coeruleus cells, suggesting that distinct neuron cells respond differently to rotenone toxicity. Rotenone induced Tau phosphorylation at Ser199/202, together with a decrease in the endogenous BAG2 protein levels in SH-SY5Y and hippocampus cell culture, which indicates that rotenone and Tau hyperphosphorylation can affect this co-chaperone. Finally, it has been shown that BAG2 overexpression, increased p62/SQSTM1 levels in cells from hippocampus and locus coeruleus, stimulated LC3II recycling as well as prevented the raise of phosphorylated Tau at Ser199/202 in hippocampus.
CONCLUSIONS: Results demonstrate a possible role for BAG2 in degradation pathways of specific substrates and its importance for the study of cellular aspects of neurodegenerative diseases.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Alpha-synuclein; Alzheimer’s disease; Autophagy; Hyperphosphorylated Tau; Parkinson’s disease; Rotenone

Mesh:

Substances:

Year:  2022        PMID: 35612780     DOI: 10.1007/s11033-022-07577-w

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  51 in total

1.  Alpha synuclein dimers and oligomers are increased in overexpressing conditions in vitro and in vivo.

Authors:  D Marmolino; P Foerch; F A Atienzar; L Staelens; A Michel; D Scheller
Journal:  Mol Cell Neurosci       Date:  2015-12-19       Impact factor: 4.314

2.  Clinical, pathologic and genetic studies on autosomal recessive early-onset parkinsonism with diurnal fluctuation.

Authors:  Y Yamamura; S Kuzuhara; K Kondo; T Yanagi; M Uchida; H Matsumine; Y Mizuno
Journal:  Parkinsonism Relat Disord       Date:  1998-08       Impact factor: 4.891

3.  APP processing and synaptic function.

Authors:  Flavio Kamenetz; Taisuke Tomita; Helen Hsieh; Guy Seabrook; David Borchelt; Takeshi Iwatsubo; Sangram Sisodia; Roberto Malinow
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

Review 4.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders.

Authors:  L Buée; T Bussière; V Buée-Scherrer; A Delacourte; P R Hof
Journal:  Brain Res Brain Res Rev       Date:  2000-08

5.  Autophagy in healthy aging and disease.

Authors:  Yahyah Aman; Tomas Schmauck-Medina; Malene Hansen; Richard I Morimoto; Anna Katharina Simon; Ivana Bjedov; Konstantinos Palikaras; Anne Simonsen; Terje Johansen; Nektarios Tavernarakis; David C Rubinsztein; Linda Partridge; Guido Kroemer; John Labbadia; Evandro F Fang
Journal:  Nat Aging       Date:  2021-08-12

Review 6.  The role of protein clearance mechanisms in organismal ageing and age-related diseases.

Authors:  David Vilchez; Isabel Saez; Andrew Dillin
Journal:  Nat Commun       Date:  2014-12-08       Impact factor: 14.919

Review 7.  Pathological and clinical aspects of alpha/beta synuclein in Parkinson's disease and related disorders.

Authors:  Michael Tolmasov; Ruth Djaldetti; Nirit Lev; Yossi Gilgun-Sherki
Journal:  Expert Rev Neurother       Date:  2016-03-25       Impact factor: 4.618

Review 8.  Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease.

Authors:  Tilman Grune; Tobias Jung; Katrin Merker; Kelvin J A Davies
Journal:  Int J Biochem Cell Biol       Date:  2004-12       Impact factor: 5.085

Review 9.  Role of axonal transport in neurodegenerative diseases.

Authors:  Kurt J De Vos; Andrew J Grierson; Steven Ackerley; Christopher C J Miller
Journal:  Annu Rev Neurosci       Date:  2008       Impact factor: 12.449

Review 10.  Autophagy as a promoter of longevity: insights from model organisms.

Authors:  Malene Hansen; David C Rubinsztein; David W Walker
Journal:  Nat Rev Mol Cell Biol       Date:  2018-09       Impact factor: 94.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.